Structure–Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against <i>Mycobacterium tuberculosis</i>
Chungen Li(Chinese Academy of Sciences), Youfu Luo(Sichuan University), Zhiyong Liu(Ministry of Public Security of the People's Republic of China), Xirong Tian(Chinese Academy of Sciences), Zongkai Huang(Sichuan University), Cong Li(Sichuan University), Song Liu(Northeast Forestry University), Tianyu Zhang(Gansu Agricultural University), Tao Yang(Sichuan University), Yanmei Wang(Shanxi University), Yamin Gao(Chinese Academy of Sciences), Qingxiang Sun(University of Electronic Science and Technology of China), Buhari Yusuf(Chinese Academy of Sciences), Xupeng Gou(Sichuan University)
Cited by 17
Related Papers
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
|Blood|2012|300
Structural Basis for the Inhibition Mechanism of Human Cystathionine γ-Lyase, an Enzyme Responsible for the Production of H2S
|Journal of Biological Chemistry|2008|206
Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
|Proceedings of the National Academy of Sciences|2013|196
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
|Leukemia|2012|193
Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition)
|World Journal of Pediatrics|2018|180